In this episode of The RevGenetics Podcast, Les and Amy explore a surprising breakthrough in respiratory health and gut microbiome research: live probiotics may offer a revolutionary way to treat severe asthma. A recent study published in Nature shows that live probiotics significantly reduce lung inflammation and asthma symptoms in mice, whereas heat-killed probiotics have no effect. Interestingly, these live bacteria don't physically travel from the stomach to the lungs—instead, they act like a remote command center in the gut, sending signals that directly influence immune cells in the respiratory system. Could targeted gut bacteria hold the key to managing chronic inflammatory lung conditions? Join us as we unpack the implications of this study and what it might mean for the future of immunity, respiratory health, and longevity science.
Podden och tillhörande omslagsbild på den här sidan tillhör
RevGenetics. Innehållet i podden är skapat av RevGenetics och inte av,
eller tillsammans med, Poddtoppen.
